The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2013 – December 7, 2013. Certain people with Medicare can also change plans at other times (see question #13). Plans are making changes to benefits and costs, and there are also new plans in many areas of the country. In 2014,...
Read more
MAPRx in Action
REVISING SPECIALTY TIERS: PROTECTING MEDICARE PART D BENEFICIARIES FROM BURDENSOME COST SHIFTING
>> Download the Report Here [PDF]
THE MAPRx COALITION RELEASES REPORT ON WAYS TO IMPROVE PATIENT PRESCRIPTION DRUG ACCESS, AS LAWMAKERS TAKE STEPS TO TACKLE ISSUE OF SPECIALTY TIERS IN MEDICARE PART D
WASHINGTON, D.C., July 25, 2013 – The MAPRx Coalition (MAPRx) today released, “Revising Specialty Tiers: Protecting Medicare Part D Beneficiaries from Burdensome...April 2013 Letter to Congress
Dear Members of Congress:
Medicare Access for Patients RX or MAPRx brings together national beneficiary, patient advocacy, family caregiver, and health professional organizations committed to ensuring and improving access to prescription medications and safeguarding the well-being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On behalf of millions of...
Read more
MAPRx Letter to Acting CMS Administrator Marilyn Tavenner
Ms. Marilyn Tavenner
Acting Administrator
Centers for Medicare and Medicaid Services
7500 Security Boulevard
Baltimore, Maryland 21244
Re: Draft 2014 Call Letter for the Medicare Advantage (MA) and Prescription Drug Programs
Dear Acting Administrator Tavenner:
On behalf of millions of Medicare beneficiaries with chronic diseases and conditions who rely on Medicare Part D for essential medications, MAPRx appreciates the opportunity...
Read more
Letter to Congress Re: Drug Benefit Design
Dear Member of Congress –
MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the well being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On behalf of millions of Medicare beneficiaries with chronic conditions who rely...
Read more
October 2012 Briefing on Capitol Hill
MAPRx Comments on Draft 2013 Medicare Call Letter
March 2, 2012
Marilyn Tavenner
Acting Administrator Centers for Medicare and Medicaid Services
7500 Security Blvd.
Baltimore, MD 21244
Dear Ms. Tavenner:
MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the well-being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On...
Read more
Letter to Congress on Proposed Part D Changes
Dear Member of Congress –
MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the well- being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On behalf of millions...
Read more
Letter to the Congressional Joint Select Committee on Deficit Reduction
The Honorable Patty Murray, Co-chair
The Honorable Jeb Hensarling, Co-chair
Joint Select Committee on Deficit Reduction
United States Congress
Washington, DC 20510
Dear Senator Murray, Rep. Hensarling, and Committee Members –
MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the...
Read more
Patient and Beneficiary Groups in MAPRx Coalition Urge Supercommittee to Protect Medicare Part D
Washington, DC — Writing on behalf of millions of Medicare beneficiaries with chronic health conditions who rely on Part D for their essential medications, 26 members of the Medicare Access for Patients Rx (MAPRx) coalition sent a joint letter urging members of the...
Read more